Generic name:ofatumumab
Dosage form: injection, for subcutaneous use
Drug classes:CD20 monoclonal antibodies, Selective immunosuppressants
What is Kesimpta?
Kesimpta is a prescription medicine used to treat adults with relapsing forms of multiple sclerosis (MS) including:
- clinically isolated syndrome
- relapsing-remitting disease
- active secondary progressive disease
It is not known if Kesimpta is safe or effective in children.
Warnings
Kesimpta can cause serious side effects, including:
- Infections. Serious infections can happen during treatment with Kesimpta. If you have an active infection, your healthcare provider should delay your treatment until your infection is gone. Kesimpta taken before or after other medicines that weaken the immune system may increase your risk of getting infections.
Tell your healthcare provider right away if you have any infections or get any symptoms, including painful and frequent urination, nasal congestion, runny nose, sore throat, fever, chills, cough, or body aches.
- Hepatitis B virus (HBV) reactivation. Before starting treatment, your healthcare provider will do blood tests to check for HBV. If you have ever had HBV infection, the HBV may become active again during or after treatment. Hepatitis B virus becoming active again (called reactivation) may cause serious liver problems, including liver failure or death. You should not receive Kesimpta if you have active hepatitis B liver disease. Your healthcare provider will monitor you for HBV infection during and after you stop using this medicine.
Tell your healthcare provider right away if you get worsening tiredness or yellowing of your skin or white part of your eyes during treatment.
- Prog...
